Cipla Limited (NSE: CIPLA) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Ankit Bhembre -- Investor Relations Ashish Adukia -- Global Chief Financial Officer
Cipla Limited (CIPLA) Q3 FY23 Earnings Concall Transcript
Categories
pharma
Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q2 FY23 Earnings Concall dated Nov. 04, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations Ashish Adukia -- Global Chief
Infographic : Gland Pharma Ltd (NSE : GLAND) Q2 Results; Total Revenue = ₹ 1110.28 million ( UP 19.7 % QoQ)
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral
Zydus Lifesciences Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/R4mbpNYrIhE Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q1 FY23 Earnings Concall Q&A Highlights: Neha enquired about the drivers of strong growth
Aurobindo Pharma Limited Q1 FY 2023 Research Tear Sheet
Stock Data Ticker: AUROPHARMA Exchange :NSE and BSE Industry: Automobile Price Performance Last 7 days 4.36% YTD -19.19% Last 12 months -28.17%
Cipla Limited (CIPLA) Q1 FY23 Earnings Concall Transcript
Cipla Limited (NSE:CIPLA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations Umang Vohra
Gland Pharma Ltd Research Tear Sheet Q1 FY 23
Gland Pharma Ltd is an Indian Pharmaceutical company. It was established in 1978, at Hyderabad, India. The founder is PVN Raju. It has
Cipla Q4 FY2022 Research Summary
Cipla is an Indian multinational pharmaceutical company. The company was incorporated in the year 1935. The founder is Khwaja Abdul Hamied. Cipla
Sun Pharmaceuticals Industries Ltd. Q4 FY 2022 Research Summary
Overview Sun Pharmaceutical Industries Limited is an Indian pharmaceutical company. The headquarters is situated in Mumbai, Maharashtra. It was incorporated in 1983.
Aurobindo Pharma Q4 FY 2022 Research Tear Sheet
Aurobindo Pharma Limited is an Indian pharmaceutical company. It was established in the year 1986. The founders include Mr. P.V. Ramprasad Reddy,
Sun Pharma Research Tear Sheet Q3 FY 2022
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company. The company was incorporated in 1983. It has its headquarter in Mumbai, Maharashtra India. The company
Aurobindo Pharma Q3 FY 2022 Research Tear Sheet
Aurobindo Pharma Limited is an Indian pharmaceutical company. It is based in HITEC City, Hyderabad, India. It was incorporated in 1986. The pharmaceutical products include
Dr. Reddy’s Laboratories Q3 FY 2022 Research Tear Sheet
Dr. Reddy's Laboratories are an Indian multinational pharmaceutical company. The company is headquartered in Hyderabad, Telangana, India and Princeton, New Jersey, U.S. It was incorporated in
Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Transcript
Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha -- Chief Investor Relations
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY22 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
Jubilant Ingrevia Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=VEV5IjVrTNI Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans shaping
Infographic: Key highlights from Sun Pharma Q3 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of
Gland Pharma Ltd (GLAND) Q3 FY22 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate participants: Sumanta Bajpayee -- Vice President- Investor Relations Srinivas
Infographic: All you need to know about Dr Reddy’s Labs Q2 performance
Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with a growth
Infographic: All you need to know about Divis Labs Q3 performance
Divi's Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release The company had net consolidated revenue of ₹2,006 crores with a growth of
Infographic: How Cipla performed in Q2 2022
Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of ₹5,580 crores with a growth of 9% year